首页 > 最新文献

Ginekologia polska最新文献

英文 中文
Successful treatment of interstitial ectopic pregnancy using methotrexate. 甲氨蝶呤成功治疗间质性异位妊娠。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-05-10 DOI: 10.5603/GP.a2023.0034
Ibrahim A Abdelazim, Svetlana Shikanova, Mohamed H Farag, Bakyt Karimova
{"title":"Successful treatment of interstitial ectopic pregnancy using methotrexate.","authors":"Ibrahim A Abdelazim, Svetlana Shikanova, Mohamed H Farag, Bakyt Karimova","doi":"10.5603/GP.a2023.0034","DOIUrl":"https://doi.org/10.5603/GP.a2023.0034","url":null,"abstract":"","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9438899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a performance assessment checklist for insertion of an intra-uterine device (IUD). 子宫内节育器(IUD)插入的性能评估清单的开发和验证。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-04-12 DOI: 10.5603/GP.a2023.0016
Stephanie Mignot, Anne-Charlotte Berthome, Marion Andre, Cyril Breque, Jean-Pierre Richer, Daniel Ghazali, Denis Oriot

Objectives: The World Health Organization (WHO) supports increasing the availability and acceptability of long-acting reversible contraception including intra-uterine device (IUD), but its insertion includes certain risks (uterine perforation). The objective was to develop and validate an IUD insertion performance assessment checklist.

Material and methods: This prospective study took place in hospitals and simulation center of the Poitou-Charentes region, France. The checklist content reached consensus among 10 experts solicited by a Delphi method. A modified gynecologic mannequin Zoe (Gaumard®) was used for simulations. Psychometric testing included 30 multi-professional participants for internal consistency and reliability between two independent observers, and 27 residents for assessment of score evolution over time and reliability. Cronbach alpha (CA) and intraclass coefficient (ICC) were used. Progression of performance was carried out using ANOVA for repeated measures. The data collected were used to plot receiver operating characteristic (ROC) curves for the score values and the area under the curve (AUC) was determined.

Results: The checklist included 27 items (2 sections, total score = 27). Psychometric testing showed CA = 0.79, ICC = 0.99, and good clinical relevance. The checklist is discriminative, showing a significant increase in performance scores when the simulations were repeated (F = 77.6, p < 0.0001). ROC curve [AUC: 0.792 (95% CI: 0.71-0.89); p < 0.0001] revealed the best score cutoff predictive of 100% sensitivity, i.e., true positive rate or success rate. Performance score was highly correlated to success rate. The cut-off score guaranteeing successful IUD insertion was 22/27.

Conclusions: This coherent and reproducible checklist for IUD insertion provide an objective assessment of the procedure during SBT, with the aim of obtaining a score ≥ 22/27.

目标:世界卫生组织(世卫组织)支持增加长效可逆避孕措施的可获得性和可接受性,包括宫内节育器(IUD),但其插入存在一定风险(子宫穿孔)。目的是开发和验证宫内节育器插入性能评估清单。材料和方法:这项前瞻性研究在法国普瓦图-夏朗德地区的医院和模拟中心进行。清单内容通过德尔菲法征求10名专家意见一致。采用改良的妇科假人Zoe (Gaumard®)进行模拟。心理测量测试包括30名多专业参与者,以评估两个独立观察者之间的内部一致性和信度,并评估27名居民的得分随时间演变和信度。采用Cronbach alpha (CA)和intraclass coefficient (ICC)。使用方差分析(ANOVA)进行重复测量。收集的数据用于绘制受试者工作特征(ROC)曲线,并确定曲线下面积(AUC)。结果:检查表共27项,分为2部分,总分27分。心理测试CA = 0.79, ICC = 0.99,临床相关性较好。检查表是判别性的,当重复模拟时,表现分数显着增加(F = 77.6, p < 0.0001)。ROC曲线[AUC: 0.792 (95% CI: 0.71-0.89);P < 0.0001]显示了100%敏感性的最佳评分截止预测,即真阳性率或成功率。成绩得分与成功率高度相关。保证宫内节育器置入成功的截止分数为22/27。结论:这一连贯且可重复的宫内节育器插入检查表提供了SBT期间手术过程的客观评估,目的是获得≥22/27的评分。
{"title":"Development and validation of a performance assessment checklist for insertion of an intra-uterine device (IUD).","authors":"Stephanie Mignot,&nbsp;Anne-Charlotte Berthome,&nbsp;Marion Andre,&nbsp;Cyril Breque,&nbsp;Jean-Pierre Richer,&nbsp;Daniel Ghazali,&nbsp;Denis Oriot","doi":"10.5603/GP.a2023.0016","DOIUrl":"https://doi.org/10.5603/GP.a2023.0016","url":null,"abstract":"<p><strong>Objectives: </strong>The World Health Organization (WHO) supports increasing the availability and acceptability of long-acting reversible contraception including intra-uterine device (IUD), but its insertion includes certain risks (uterine perforation). The objective was to develop and validate an IUD insertion performance assessment checklist.</p><p><strong>Material and methods: </strong>This prospective study took place in hospitals and simulation center of the Poitou-Charentes region, France. The checklist content reached consensus among 10 experts solicited by a Delphi method. A modified gynecologic mannequin Zoe (Gaumard®) was used for simulations. Psychometric testing included 30 multi-professional participants for internal consistency and reliability between two independent observers, and 27 residents for assessment of score evolution over time and reliability. Cronbach alpha (CA) and intraclass coefficient (ICC) were used. Progression of performance was carried out using ANOVA for repeated measures. The data collected were used to plot receiver operating characteristic (ROC) curves for the score values and the area under the curve (AUC) was determined.</p><p><strong>Results: </strong>The checklist included 27 items (2 sections, total score = 27). Psychometric testing showed CA = 0.79, ICC = 0.99, and good clinical relevance. The checklist is discriminative, showing a significant increase in performance scores when the simulations were repeated (F = 77.6, p < 0.0001). ROC curve [AUC: 0.792 (95% CI: 0.71-0.89); p < 0.0001] revealed the best score cutoff predictive of 100% sensitivity, i.e., true positive rate or success rate. Performance score was highly correlated to success rate. The cut-off score guaranteeing successful IUD insertion was 22/27.</p><p><strong>Conclusions: </strong>This coherent and reproducible checklist for IUD insertion provide an objective assessment of the procedure during SBT, with the aim of obtaining a score ≥ 22/27.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9277228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of gestational diabetes mellitus on outcomes of preinduced labour with dinoprostone vaginal insert. 妊娠期糖尿病对迪诺前列酮阴道插入物引产结局的影响。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-28 DOI: 10.5603/GP.a2023.0030
Magdalena Kolak, Katarzyna Skibinska, Magda Rybak-Krzyszkowska, Agnieszka Micek, Tomasz Gora, Hubert Huras, Andrzej P Jaworowski

Objectives: The aim of this study was to evaluate the effectiveness of labour preinduction using a dinoprostone vaginal insert in patients with gestational diabetes mellitus versus patients undergoing labour induction for other causes. The second aim of the study was to compare perinatal outcomes in both groups.

Material and methods: The study has a retrospective character, conducted in 2019-2021 in a tertiary reference hospital. The following endpoints were assumed for the analysis: natural childbirth, birth occurring within 12 hours of dinoprostone administration and neonatal outcomes. Furthermore, indications of a Caesarean section were analysed.

Results: The percentage of natural childbirths was similar in both groups. Furthermore, in both groups, over 80% of patients gave birth within less than 12 hours following dinoprostone administration. Neonatal outcomes (body weight, Apgar score) did not differ statistically. Analysing indications for a Caesarean section, failure in the progress of labour was an indication in 39.5% of cases in the control group, 29.4% of cases in gestational diabetes mellitus (GDM), and 50% of cases in diabetes mellitus (DM). The risk of foetal asphyxia was an indication in 55.8% of cases in the control group, 35.3% of cases in GDM and 50% of cases in DM. Ineffective labour induction - no induction of the contractile function was an indication for a C-section in 4.7% of cases in the control group and 35.3% of cases in GDM; no cases were noted in DM (p = 0.024).

Conclusions: The study demonstrated that patients undergoing labour induction due to GDM using a dinoprostone vaginal insert did not differ in terms of labour duration, oxytocin administration compared to patients undergoing labour induction for other causes. Furthermore, the same rate of Caesarean sections was found in the study group; however, these groups differ in terms of indications, including risk of foetal asphyxia (35.3% vs 55.8%), failure in the progress of labour (29.4% vs 39.5%), and no active labour (1.8% vs 1.5%). The neonatal Apgar score at 1.5 and 10 minutes after birth was similar in both groups.

目的:本研究的目的是评估使用迪诺前列酮阴道插入物对妊娠期糖尿病患者和其他原因引产的患者的引产效果。研究的第二个目的是比较两组的围产期结果。材料和方法:本研究为回顾性研究,于2019-2021年在一家三级参考医院进行。本分析假设以下终点:自然分娩、使用迪诺前列酮后12小时内分娩和新生儿结局。此外,还分析了剖宫产的指征。结果:两组自然分娩率相近。此外,在两组中,超过80%的患者在给药后不到12小时内分娩。新生儿结局(体重、Apgar评分)无统计学差异。分析剖宫产的指征,39.5%的对照组、29.4%的妊娠期糖尿病(GDM)和50%的糖尿病(DM)患者的指征是分娩过程失败。在对照组55.8%的病例中,胎儿窒息的危险是指征,在GDM病例中为35.3%,在DM病例中为50%。在4.7%的对照组病例和35.3%的GDM病例中,引产无效——没有诱导收缩功能是剖腹产的指征;DM组无病例(p = 0.024)。结论:该研究表明,与其他原因引产的患者相比,使用迪诺前列石阴道插入物进行GDM引产的患者在分娩持续时间、催产素给药方面没有差异。此外,在研究组中发现了相同的剖腹产率;然而,这些组在适应症方面存在差异,包括胎儿窒息的风险(35.3%对55.8%),分娩过程中失败(29.4%对39.5%)和无活动性分娩(1.8%对1.5%)。两组新生儿出生后1.5分钟和10分钟的Apgar评分相似。
{"title":"Influence of gestational diabetes mellitus on outcomes of preinduced labour with dinoprostone vaginal insert.","authors":"Magdalena Kolak,&nbsp;Katarzyna Skibinska,&nbsp;Magda Rybak-Krzyszkowska,&nbsp;Agnieszka Micek,&nbsp;Tomasz Gora,&nbsp;Hubert Huras,&nbsp;Andrzej P Jaworowski","doi":"10.5603/GP.a2023.0030","DOIUrl":"https://doi.org/10.5603/GP.a2023.0030","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to evaluate the effectiveness of labour preinduction using a dinoprostone vaginal insert in patients with gestational diabetes mellitus versus patients undergoing labour induction for other causes. The second aim of the study was to compare perinatal outcomes in both groups.</p><p><strong>Material and methods: </strong>The study has a retrospective character, conducted in 2019-2021 in a tertiary reference hospital. The following endpoints were assumed for the analysis: natural childbirth, birth occurring within 12 hours of dinoprostone administration and neonatal outcomes. Furthermore, indications of a Caesarean section were analysed.</p><p><strong>Results: </strong>The percentage of natural childbirths was similar in both groups. Furthermore, in both groups, over 80% of patients gave birth within less than 12 hours following dinoprostone administration. Neonatal outcomes (body weight, Apgar score) did not differ statistically. Analysing indications for a Caesarean section, failure in the progress of labour was an indication in 39.5% of cases in the control group, 29.4% of cases in gestational diabetes mellitus (GDM), and 50% of cases in diabetes mellitus (DM). The risk of foetal asphyxia was an indication in 55.8% of cases in the control group, 35.3% of cases in GDM and 50% of cases in DM. Ineffective labour induction - no induction of the contractile function was an indication for a C-section in 4.7% of cases in the control group and 35.3% of cases in GDM; no cases were noted in DM (p = 0.024).</p><p><strong>Conclusions: </strong>The study demonstrated that patients undergoing labour induction due to GDM using a dinoprostone vaginal insert did not differ in terms of labour duration, oxytocin administration compared to patients undergoing labour induction for other causes. Furthermore, the same rate of Caesarean sections was found in the study group; however, these groups differ in terms of indications, including risk of foetal asphyxia (35.3% vs 55.8%), failure in the progress of labour (29.4% vs 39.5%), and no active labour (1.8% vs 1.5%). The neonatal Apgar score at 1.5 and 10 minutes after birth was similar in both groups.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9192562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study on the effect of remifentanil patient-controlled intravenous labor analgesia compared to patient-controlled epidural labor analgesia. 瑞芬太尼病人自控静脉分娩镇痛与病人自控硬膜外分娩镇痛的临床比较。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-28 DOI: 10.5603/GP.a2023.0021
Haibin Li, Hui Li, Yibing Yu, Yan Lu

Objectives: This study aims to investigate the safety and efficacy of remifentanil for patient-controlled intravenous labor analgesia as an alternative to the patient-controlled epidural labor analgesia.

Material and: METHODS: Out of 453 parturients who volunteered for labor analgesia and were selected as research objects, 407 completed the trial. They were divided into the research group (n = 148) and the control group (n = 259; patient-controlled epidural analgesia). In the research group, the first dose of remifentanil, the background dose and the patient-controlled analgesia (PCA) dose were 0.4 μg/kg, 0.04 μg/min and 0.4 μg/kg, respectively, with a lockout interval of 3 min. The control group was given epidural analgesia. The first dose and background dose were 6-8 mL, and PCA dose and the locking time of analgesia pump were 5 mL and 20 min, respectively. The following indexes of the two groups were observed and recorded: the analgesic and sedative effects on parturient, labor process, forceps delivery, cesarean section rate and adverse reactions, and maternal and neonatal conditions.

Results: 1. The onset time of analgesia in the research group was (0.97 ± 0.08) min, which was noticeably shorter than that in the control group ([15.74 ± 1.91] min), with a statistically significant difference (t = -93.979, p = 0.000). 2. There was no significant difference in the labor process, forceps delivery, cesarean section rate and neonatal condition between the two groups (p > 0.05).

Conclusions: Remifentanil patient-controlled intravenous labor analgesia has the advantage of rapid onset of labor analgesia. Although its analgesic effect is not as accurate and stable as epidural patient-controlled labor analgesia, it shows a high level of maternal and family satisfaction.

目的:本研究旨在探讨瑞芬太尼作为病人自控的静脉分娩镇痛替代病人自控的硬膜外分娩镇痛的安全性和有效性。材料与方法:在453例自愿使用分娩镇痛的产妇中,407例完成了试验。将患者分为研究组(n = 148)和对照组(n = 259);患者控制硬膜外镇痛)。研究组给予瑞芬太尼首次剂量、背景剂量和患者自控镇痛(PCA)剂量分别为0.4 μg/kg、0.04 μg/min和0.4 μg/kg,闭锁时间为3 min。对照组给予硬膜外镇痛。首次给药剂量6 ~ 8 mL,背景给药剂量6 ~ 8 mL, PCA给药剂量5 mL,镇痛泵锁定时间20 min。观察并记录两组患者镇痛镇静效果、产程、产钳分娩、剖宫产率及不良反应、母婴情况。结果:1。研究组镇痛起效时间为(0.97±0.08)min,明显短于对照组([15.74±1.91]min),差异有统计学意义(t = -93.979, p = 0.000)。2. 两组产程、产钳娩出、剖宫产率及新生儿状况比较,差异均无统计学意义(p > 0.05)。结论:瑞芬太尼患者自控静脉分娩镇痛具有起效快的优点。虽然其镇痛效果不如硬膜外患者自控分娩镇痛准确和稳定,但其产妇和家庭满意度较高。
{"title":"Clinical study on the effect of remifentanil patient-controlled intravenous labor analgesia compared to patient-controlled epidural labor analgesia.","authors":"Haibin Li,&nbsp;Hui Li,&nbsp;Yibing Yu,&nbsp;Yan Lu","doi":"10.5603/GP.a2023.0021","DOIUrl":"https://doi.org/10.5603/GP.a2023.0021","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to investigate the safety and efficacy of remifentanil for patient-controlled intravenous labor analgesia as an alternative to the patient-controlled epidural labor analgesia.</p><p><strong>Material and: </strong>METHODS: Out of 453 parturients who volunteered for labor analgesia and were selected as research objects, 407 completed the trial. They were divided into the research group (n = 148) and the control group (n = 259; patient-controlled epidural analgesia). In the research group, the first dose of remifentanil, the background dose and the patient-controlled analgesia (PCA) dose were 0.4 μg/kg, 0.04 μg/min and 0.4 μg/kg, respectively, with a lockout interval of 3 min. The control group was given epidural analgesia. The first dose and background dose were 6-8 mL, and PCA dose and the locking time of analgesia pump were 5 mL and 20 min, respectively. The following indexes of the two groups were observed and recorded: the analgesic and sedative effects on parturient, labor process, forceps delivery, cesarean section rate and adverse reactions, and maternal and neonatal conditions.</p><p><strong>Results: </strong>1. The onset time of analgesia in the research group was (0.97 ± 0.08) min, which was noticeably shorter than that in the control group ([15.74 ± 1.91] min), with a statistically significant difference (t = -93.979, p = 0.000). 2. There was no significant difference in the labor process, forceps delivery, cesarean section rate and neonatal condition between the two groups (p > 0.05).</p><p><strong>Conclusions: </strong>Remifentanil patient-controlled intravenous labor analgesia has the advantage of rapid onset of labor analgesia. Although its analgesic effect is not as accurate and stable as epidural patient-controlled labor analgesia, it shows a high level of maternal and family satisfaction.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9192564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual function in women with pelvic organ prolapse and surgery influence on their complaints. 盆腔器官脱垂女性的性功能及手术对其主诉的影响。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-28 DOI: 10.5603/GP.a2023.0029
Magdalena Zietarska Cisak, Aneta Zwierzchowska, Ewa Barcz, Edyta Horosz

Sexual health is an essential component of women's wellbeing. Women with pelvic organ prolapse (POP) often suffer from sexual dysfunction. The current review focuses on the impact of POP as well as surgical POP repair on sexual function. A variety of techniques are discussed in relation to this issue, including native tissue repair (NTR), transvaginal mesh (TVM) and sacrocolpopexy (SCP). The majority of studies utilise validated questionnaires to assess sexual function in women pre- and post-POP repair and FSFI (Female Sexual Function Index) and PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA revised) are among the most commonly used. According to the available data, surgical management of POP usually results in improved or unchanged scores in sexual function, regardless of the type of procedure used. SCP appears to be the preferred surgical management for women with apical vaginal prolapse that minimises the risk of dyspareunia as compared to vaginal techniques.

性健康是妇女福祉的重要组成部分。盆腔器官脱垂(POP)的女性常伴有性功能障碍。现就POP对性功能的影响及手术修复作一综述。讨论了多种与此相关的技术,包括天然组织修复(NTR),经阴道补片(TVM)和骶colpopexy (SCP)。大多数研究使用有效的问卷来评估女性在pop修复前后的性功能,FSFI(女性性功能指数)和PISQ-IR(盆腔器官脱出/尿失禁性问卷- iuga修订版)是最常用的。根据现有资料,无论采用何种手术方式,手术治疗POP通常会改善或保持性功能评分不变。与阴道技术相比,SCP似乎是阴道顶端脱垂女性的首选手术治疗方法,可将性交困难的风险降至最低。
{"title":"Sexual function in women with pelvic organ prolapse and surgery influence on their complaints.","authors":"Magdalena Zietarska Cisak,&nbsp;Aneta Zwierzchowska,&nbsp;Ewa Barcz,&nbsp;Edyta Horosz","doi":"10.5603/GP.a2023.0029","DOIUrl":"https://doi.org/10.5603/GP.a2023.0029","url":null,"abstract":"<p><p>Sexual health is an essential component of women's wellbeing. Women with pelvic organ prolapse (POP) often suffer from sexual dysfunction. The current review focuses on the impact of POP as well as surgical POP repair on sexual function. A variety of techniques are discussed in relation to this issue, including native tissue repair (NTR), transvaginal mesh (TVM) and sacrocolpopexy (SCP). The majority of studies utilise validated questionnaires to assess sexual function in women pre- and post-POP repair and FSFI (Female Sexual Function Index) and PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA revised) are among the most commonly used. According to the available data, surgical management of POP usually results in improved or unchanged scores in sexual function, regardless of the type of procedure used. SCP appears to be the preferred surgical management for women with apical vaginal prolapse that minimises the risk of dyspareunia as compared to vaginal techniques.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9192563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prenatal karyotype results from 2169 invasive tests. 2169次侵入性检查的产前核型结果。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-28 DOI: 10.5603/GP.a2022.0143
Hanna Moczulska, Marta Chrzanowska-Steglinska, Beata Skoczylas, Katarzyna Wojda, Maciej Borowiec, Piotr Sieroszewski

Objectives: Foetal karyotyping is a basic tool used to diagnose the most common genetic syndromes. Although new molecular methods such as FISH, MLPA or QF-PCR allow rapid prenatal testing, they are of limited value when diagnosing less frequent chromosomal abnormalities. Chromosomal microarray analysis offers higher test resolution than traditional karyotyping and has been recommended as first-line genetic testing in prenatal diagnosis. The aim of the study was to confirm whether foetal karyotyping remains a valid approach to prenatal diagnosis by analysing its performance in a large population of pregnant women with a high risk of chromosomal aberration.

Material and methods: An analysis was performed of 2169 foetal karyotypes from two referral university centres for prenatal diagnostics in Lodz, Poland.

Results: Amniocentesis and foetal karyotyping were performed when screening methods had indicated a high risk of chromosomal aberration, or when prenatal ultrasound had proved foetal abnormality. The study group included 205 (9.4%) abnormal foetal karyotypes. Rare aberrations were observed in 34 cases (e.g., translocations, inversions, deletions and duplication). A marker chromosome was present in five cases.

Conclusions: One third of the chromosomal abnormalities observed in the prenatal tests were rarer aberrations (i.e., not trisomy 21, 18 or 13). As many of these could not be detected by the new molecular methods, foetal karyotyping remains an important component of prenatal diagnosis.

目的:胎儿核型是诊断最常见遗传综合征的基本工具。虽然新的分子方法,如FISH, MLPA或QF-PCR允许快速产前检测,但它们在诊断不太常见的染色体异常时价值有限。染色体微阵列分析比传统的核型分析具有更高的检测分辨率,已被推荐作为产前诊断的一线基因检测。该研究的目的是确认胎儿核型是否仍然是一种有效的产前诊断方法,通过分析其在大量染色体畸变高风险孕妇中的表现。材料和方法:对波兰罗兹两所产前诊断转诊大学中心的2169例胎儿核型进行了分析。结果:当筛查方法提示染色体畸变高危或产前超声证实胎儿异常时,应进行羊膜穿刺术和胎儿核型分析。研究组有205例(9.4%)胎儿核型异常。34例观察到罕见的畸变(如易位、倒位、缺失和重复)。有5例存在标记染色体。结论:在产前检查中观察到的染色体异常中有三分之一是罕见的畸变(即不是21、18或13三体)。由于其中许多无法通过新的分子方法检测到,胎儿核型仍然是产前诊断的重要组成部分。
{"title":"Prenatal karyotype results from 2169 invasive tests.","authors":"Hanna Moczulska,&nbsp;Marta Chrzanowska-Steglinska,&nbsp;Beata Skoczylas,&nbsp;Katarzyna Wojda,&nbsp;Maciej Borowiec,&nbsp;Piotr Sieroszewski","doi":"10.5603/GP.a2022.0143","DOIUrl":"https://doi.org/10.5603/GP.a2022.0143","url":null,"abstract":"<p><strong>Objectives: </strong>Foetal karyotyping is a basic tool used to diagnose the most common genetic syndromes. Although new molecular methods such as FISH, MLPA or QF-PCR allow rapid prenatal testing, they are of limited value when diagnosing less frequent chromosomal abnormalities. Chromosomal microarray analysis offers higher test resolution than traditional karyotyping and has been recommended as first-line genetic testing in prenatal diagnosis. The aim of the study was to confirm whether foetal karyotyping remains a valid approach to prenatal diagnosis by analysing its performance in a large population of pregnant women with a high risk of chromosomal aberration.</p><p><strong>Material and methods: </strong>An analysis was performed of 2169 foetal karyotypes from two referral university centres for prenatal diagnostics in Lodz, Poland.</p><p><strong>Results: </strong>Amniocentesis and foetal karyotyping were performed when screening methods had indicated a high risk of chromosomal aberration, or when prenatal ultrasound had proved foetal abnormality. The study group included 205 (9.4%) abnormal foetal karyotypes. Rare aberrations were observed in 34 cases (e.g., translocations, inversions, deletions and duplication). A marker chromosome was present in five cases.</p><p><strong>Conclusions: </strong>One third of the chromosomal abnormalities observed in the prenatal tests were rarer aberrations (i.e., not trisomy 21, 18 or 13). As many of these could not be detected by the new molecular methods, foetal karyotyping remains an important component of prenatal diagnosis.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9192565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactoferrin supplementation during pregnancy - a review of the literature and current recommendations. 妊娠期间乳铁蛋白补充-文献综述和当前建议。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-17 DOI: 10.5603/GP.a2023.0020
Paulina Gawel, Barbara Krolak-Olejnik

Pregnancy is a period which requires special care and attention. Maintaining health during pregnancy helps to avoid birth related complications and is the best way of promoting a healthy birth. Besides a daily intake of folic acid, iron, iodine, vitamin D3 and A, calcium and polyunsaturated fatty-acids, as recommended by health agencies, supplementation of lactoferrin - a protein of multidirectional biological activity and proven safety of use - seems to be beneficial. A wide range of lactoferrin biological roles (including regulation of iron balance, modulation of immune responses, antimicrobial, antiviral, antioxidant, and anti-inflammatory activity) may contribute to better pregnancy and birth related outcomes.

怀孕是一个需要特别照顾和注意的时期。在怀孕期间保持健康有助于避免与分娩有关的并发症,是促进健康分娩的最佳方式。除了按照卫生机构的建议每天摄入叶酸、铁、碘、维生素D3和a、钙和多不饱和脂肪酸外,补充乳铁蛋白(一种具有多向生物活性且经证实使用安全的蛋白质)似乎也有益。乳铁蛋白广泛的生物学作用(包括铁平衡的调节、免疫反应的调节、抗菌、抗病毒、抗氧化和抗炎活性)可能有助于更好的妊娠和分娩相关结果。
{"title":"Lactoferrin supplementation during pregnancy - a review of the literature and current recommendations.","authors":"Paulina Gawel,&nbsp;Barbara Krolak-Olejnik","doi":"10.5603/GP.a2023.0020","DOIUrl":"https://doi.org/10.5603/GP.a2023.0020","url":null,"abstract":"<p><p>Pregnancy is a period which requires special care and attention. Maintaining health during pregnancy helps to avoid birth related complications and is the best way of promoting a healthy birth. Besides a daily intake of folic acid, iron, iodine, vitamin D3 and A, calcium and polyunsaturated fatty-acids, as recommended by health agencies, supplementation of lactoferrin - a protein of multidirectional biological activity and proven safety of use - seems to be beneficial. A wide range of lactoferrin biological roles (including regulation of iron balance, modulation of immune responses, antimicrobial, antiviral, antioxidant, and anti-inflammatory activity) may contribute to better pregnancy and birth related outcomes.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9492538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Could pelvic floor sonography be a standalone method for excluding genuine stress urinary incontinence in women? 盆底超声能作为排除女性压力性尿失禁的独立方法吗?
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-17 DOI: 10.5603/GP.a2023.0026
Mariusz Malmur, Jakub Mlodawski, Marta Mlodawska, Marcin Misiek, Olga Adamczyk-Gruszka, Piotr Niziurski, Stanislaw Gluszek, Wojciech Rokita

Objectives: Determine whether introital pelvic floor sonography with transvaginal probe (PFS-TV) can be an independent method in the diagnosis of genuine stress urinary incontinence (SUI) and to create a ultrasonographic diagnostic model to objectify diagnostic process.

Material and methods: The study involved 315 patients with a history of urinary incontinence problems. Based on the clinical examination and urodynamic examination, the final diagnosis was made. Patients were divided into two groups. Group I included women with SUI and Group II included patients without SUI (OAB and no-UI). Each patient underwent PFS-TV at rest and during straining. The groups were compared in terms of ultrasound parameters.

Results: Patients from both groups differed statistically in a significant way (p < 0.05) in terms of mean distance between the lower edge of the pubic symphysis at rest 19 mm vs 22 mm (Group I vs Group II) and during straining (D1 and D2) 22 mm vs 26 mm, the average value of the γ angle (at rest (γ1) 37.5° vs 40° and during straining (γ2) and 66° vs 58.5°, average difference value of angle γ during straining and at rest (γ2-γ1) 29° vs 14°, and frequency of urethral funneling 89% vs 17%. Two parameters studied during PFS-TV were included in the logistic regression model used to exclude the stress component of urinary incontinence. Diagnostic test parameters of model were sensitivity 86.6%, specificity 90.4%, accuracy 93.1%.

Conclusions: PFS-TV makes it possible to exclude the stress component of urinary incontinence. The developed logistic regression model allows for the objectification of the results of ultrasound examination in patients with urinary incontinence.

目的:探讨经阴道探头盆底超声(PFS-TV)能否作为诊断真性压力性尿失禁(SUI)的独立方法,建立超声诊断模型,使诊断过程客观化。材料和方法:本研究纳入315例有尿失禁病史的患者。根据临床检查和尿动力学检查,最终诊断。患者分为两组。组1包括有SUI的女性,组2包括无SUI的患者(OAB和无ui)。每位患者在休息和紧张时均接受PFS-TV。比较两组超声参数。结果:患者两组不同统计上显著地(p < 0.05)之间的平均距离在耻骨联合下缘静止19毫米vs 22毫米(组我vs组II)在紧张(D1和D2) 22毫米vs 26毫米,γ角的平均值(静止(γ1)37.5°vs 40°,在紧张(γ2)和66°vs 58.5°角γ的平均差值在紧张和静止(γ2 -γ1)29°vs 14°,和尿道的频率将89%比17%。在PFS-TV中研究的两个参数被纳入逻辑回归模型,用于排除尿失禁的压力成分。模型诊断试验参数敏感性86.6%,特异性90.4%,准确性93.1%。结论:PFS-TV可以排除尿失禁的应激成分。发展的逻辑回归模型允许客观的结果超声检查患者尿失禁。
{"title":"Could pelvic floor sonography be a standalone method for excluding genuine stress urinary incontinence in women?","authors":"Mariusz Malmur,&nbsp;Jakub Mlodawski,&nbsp;Marta Mlodawska,&nbsp;Marcin Misiek,&nbsp;Olga Adamczyk-Gruszka,&nbsp;Piotr Niziurski,&nbsp;Stanislaw Gluszek,&nbsp;Wojciech Rokita","doi":"10.5603/GP.a2023.0026","DOIUrl":"https://doi.org/10.5603/GP.a2023.0026","url":null,"abstract":"<p><strong>Objectives: </strong>Determine whether introital pelvic floor sonography with transvaginal probe (PFS-TV) can be an independent method in the diagnosis of genuine stress urinary incontinence (SUI) and to create a ultrasonographic diagnostic model to objectify diagnostic process.</p><p><strong>Material and methods: </strong>The study involved 315 patients with a history of urinary incontinence problems. Based on the clinical examination and urodynamic examination, the final diagnosis was made. Patients were divided into two groups. Group I included women with SUI and Group II included patients without SUI (OAB and no-UI). Each patient underwent PFS-TV at rest and during straining. The groups were compared in terms of ultrasound parameters.</p><p><strong>Results: </strong>Patients from both groups differed statistically in a significant way (p < 0.05) in terms of mean distance between the lower edge of the pubic symphysis at rest 19 mm vs 22 mm (Group I vs Group II) and during straining (D1 and D2) 22 mm vs 26 mm, the average value of the γ angle (at rest (γ1) 37.5° vs 40° and during straining (γ2) and 66° vs 58.5°, average difference value of angle γ during straining and at rest (γ2-γ1) 29° vs 14°, and frequency of urethral funneling 89% vs 17%. Two parameters studied during PFS-TV were included in the logistic regression model used to exclude the stress component of urinary incontinence. Diagnostic test parameters of model were sensitivity 86.6%, specificity 90.4%, accuracy 93.1%.</p><p><strong>Conclusions: </strong>PFS-TV makes it possible to exclude the stress component of urinary incontinence. The developed logistic regression model allows for the objectification of the results of ultrasound examination in patients with urinary incontinence.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does body mass index affect anti-mullerian hormone levels in girls and adolescents? 体重指数会影响女孩和青少年的抗苗勒管激素水平吗?
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-17 DOI: 10.5603/GP.a2023.0013
Iwona Czech, Mirosław Partyka, Agnieszka Drosdzol-Cop

Anti-mullerian hormone (AMH) is a dimeric glycoprotein which belongs to the transforming growth factor-beta superfamily. In women, it is produced by granulosa cells in pre-antral and small antral follicles. In recent years, there has been a continuous increase in obesity among children and adolescents. There are few studies that present AMH concentrations in premenarcheal and early postmenarcheal girls. The purpose of this work is to assess whether AMH levels were associated with body mass index (BMI) in adolescent girls before and after menarche. The study was performed at the Pediatric Endocrinology Department and Outpatient Clinic at Upper Silesian Child Health Center. 82 girls were enrolled to the study. Body mass index seems not to affect the AMH levels in adolescents, however a special attention must be given when interpreting AMH levels in girls with irregular menstrual cycles and observed for PCOS.

抗苗勒管激素(AMH)是一种二聚体糖蛋白,属于转化生长因子超家族。在女性中,它是由前腔和小腔卵泡中的颗粒细胞产生的。近年来,儿童和青少年中的肥胖人数持续增加。很少有研究表明AMH浓度在月经初潮前和月经初潮后早期的女孩。这项工作的目的是评估AMH水平是否与初潮前后青春期女孩的体重指数(BMI)相关。该研究在上西里西亚儿童健康中心的儿科内分泌科和门诊进行,共有82名女孩参加了研究。身体质量指数似乎不影响青少年的AMH水平,然而,在解释月经周期不规律和观察到多囊卵巢综合征的女孩的AMH水平时,必须给予特别注意。
{"title":"Does body mass index affect anti-mullerian hormone levels in girls and adolescents?","authors":"Iwona Czech,&nbsp;Mirosław Partyka,&nbsp;Agnieszka Drosdzol-Cop","doi":"10.5603/GP.a2023.0013","DOIUrl":"https://doi.org/10.5603/GP.a2023.0013","url":null,"abstract":"<p><p>Anti-mullerian hormone (AMH) is a dimeric glycoprotein which belongs to the transforming growth factor-beta superfamily. In women, it is produced by granulosa cells in pre-antral and small antral follicles. In recent years, there has been a continuous increase in obesity among children and adolescents. There are few studies that present AMH concentrations in premenarcheal and early postmenarcheal girls. The purpose of this work is to assess whether AMH levels were associated with body mass index (BMI) in adolescent girls before and after menarche. The study was performed at the Pediatric Endocrinology Department and Outpatient Clinic at Upper Silesian Child Health Center. 82 girls were enrolled to the study. Body mass index seems not to affect the AMH levels in adolescents, however a special attention must be given when interpreting AMH levels in girls with irregular menstrual cycles and observed for PCOS.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy-associated gastric cancer. 妊娠相关胃癌。
IF 1.3 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2023-03-17 DOI: 10.5603/GP.a2023.0008
Ewelina Stefanowicz, Piotr Minowski, Maja Bronk, Krzysztof Preis, Malgorzata Swiatkowska-Freund

Gastric cancer is a very uncommon diagnosis in pregnancy (app. 1/1000 pregnant women), which has a significant impact on the health and life of mother and fetus and can impede the diagnostic and therapeutic process. Oncological vigilance, not underestimating the symptoms, and decisions made ahead of time could increase the chances of survival. Authors are describing the case of pregnancy-associated gastric cancer, diagnosed on the basis of the histopathological result from samples taken during a laparotomy with cesarean section performed due to a suspected gastrointestinal perforation in the 3rd trimester of pregnancy.

胃癌是妊娠期非常罕见的诊断(约1/1000孕妇),严重影响母胎健康和生命,阻碍诊断和治疗进程。对肿瘤保持警惕,不要低估症状,提前做出决定可以增加生存的机会。作者描述了妊娠相关胃癌的病例,根据组织病理学结果,在剖腹手术和剖宫产手术中,由于怀疑在妊娠晚期出现胃肠道穿孔,进行了诊断。
{"title":"Pregnancy-associated gastric cancer.","authors":"Ewelina Stefanowicz,&nbsp;Piotr Minowski,&nbsp;Maja Bronk,&nbsp;Krzysztof Preis,&nbsp;Malgorzata Swiatkowska-Freund","doi":"10.5603/GP.a2023.0008","DOIUrl":"https://doi.org/10.5603/GP.a2023.0008","url":null,"abstract":"<p><p>Gastric cancer is a very uncommon diagnosis in pregnancy (app. 1/1000 pregnant women), which has a significant impact on the health and life of mother and fetus and can impede the diagnostic and therapeutic process. Oncological vigilance, not underestimating the symptoms, and decisions made ahead of time could increase the chances of survival. Authors are describing the case of pregnancy-associated gastric cancer, diagnosed on the basis of the histopathological result from samples taken during a laparotomy with cesarean section performed due to a suspected gastrointestinal perforation in the 3rd trimester of pregnancy.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ginekologia polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1